Process Targeting Of Multi-Characteristic Product Using Fuzzy Logic And Genetic Algorithm With An Interval Based Taguchi Cost Function

In this paper, a fuzzy based process targeting model is developed for a product with multi-characteristic. It is assumed that the desired quality characteristics cannot be measured directly and has to be calculated indirectly from multi-input process parameters. A fuzzy relation between observed/input parameters and required/output characteristics is proposed. A genetic algorithm is developed to obtain optimal process targets. The utility of the proposed model and algorithm is illustrated by a realistic example

The mycobiota of herbal drug plants in Oman and possible decontamination by gamma radiation

The mycobiota of seven herbal plant species were surveyed: Nigella sativa, Zataria multiflora, Trigonella foenum-graecum, Rhazya stricta (seeds and leaves), Haplophyllum tuberculatum, Aristolochia bracteolata and Teucrium muscatense. A total of 24 species of fungi were isolated from the plants (seeds, leaves, flowers and/or stems). No significant differences were found between the mycobiota of the herbal plant species or between the six samples of each plant. Aspergillus niger and Penicillium sp. were the most common species, followed by A. flavus and Rhizopus spp. A. flavus was found in all herbal plants except R. stricta (leaves) and Z. multiflora. Aflatoxins were extracted from a number of herbal plants. Some strains of A. flavus isolated from the plants were aflatoxigenic. Gamma radiation at 905.4 Gy showed an average percent inhibition of fungi on some herbal plants between 88.6 and 99.1%. Complete inhibition was obtained at 1836 Gy

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome

Incorporation of vitamin E in poly(3hydroxybutyrate)/Bioglass composite films: effect on surface properties and cell attachment

This study investigated the possibility of incorporating α-tocopherol (vitamin E) into poly(3hydroxybutyrate) (P(3HB))/Bioglass composites, which are being developed for bone tissue engineering matrices. P(3HB) films with 20 wt% Bioglass and 10 wt% vitamin E were prepared using the solvent casting technique. Addition of vitamin E significantly improved the hydrophilicity of the composites along with increasing the total protein adsorption. The presence of protein adsorbed on the composite surface was further confirmed using X-ray photoelectron spectroscopy analysis. Preliminary cell culture studies using MG-63 human osteoblasts showed that the addition of vitamin E in the P(3HB)/20 wt% Bioglass films significantly increased cell proliferation. The results achieved in this study confirmed the possibility of incorporating vitamin E as a suitable additive in P(3HB)/Bioglass composites to engineer the surface of the composites by promoting higher protein adsorption and increasing the hydrophilicity